Target intelligence / Profile preview

RDX pseudogene 3 (RDXP3)

Target
RDXP3
Molecular classification
Other (Pseudogene)
01

Overview

RDX pseudogene 3 (RDXP3) is a **pseudogene** corresponding in sequence to the functional radixin (RDX) gene but does not produce a functional protein product[7]. Like other pseudogenes, RDXP3 is considered a non-functional remnant of a gene that arose through duplication or retrotransposition and subsequently lost its protein-coding ability through mutation or truncation[8]. There is currently no evidence that RDXP3 is involved in any disease processes or acts as a therapeutic target. The radixin gene, to which it is related, encodes a cytoskeletal protein important for linking actin to the plasma membrane[1][3][5], but the pseudogene itself does not share these functions. Key useful distinctions: - RDXP3 is not the same as RDX; only RDX codes for a functional protein[5]. - Pseudogenes, by definition, are not conventional therapeutic targets. - Unless otherwise reported in specialized literature, RDXP3 has no known role in disease, biomarker use, or as a drug target. If you require information about the functional RDX protein or gene, it is a cytoskeletal linker protein in the ERM family involved in actin-membrane interactions and various cellular processes[1][3][5]. RDXP3, however, does not share these biological functions.

Other names
radixin pseudogene 3RDXP3

Beyond the preview

Go deeper on RDX pseudogene 3 (RDXP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RDX pseudogene 3 (RDXP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call